- Presentations
- 4
- Markets
- 1
Omvoh is a brand of Mirikizumab marketed by Eli Lilly, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Mirikizumab
- Brand owner
- Eli Lilly
- Registered in
- United States
- Strengths and forms
- 100 mg/1 mL injection, 200 mg/2 mL injection, 300 mg/15 mL injection, kit
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Omvoh 100 mg/1 mL injectionSubcutaneous Cold chain | Eli Lilly | US FDA | Available on request |
| Omvoh 200 mg/2 mL injectionSubcutaneous Cold chain | Eli Lilly | US FDA | Available on request |
| Omvoh 300 mg/15 mL injectionIntravenous Cold chain | Eli Lilly | US FDA | Available on request |
| Omvoh kitSubcutaneous Cold chain | Eli Lilly | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Omvoh
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.